Global Cardiac Glycosides Market Growth 2026-2032
The global Cardiac Glycosides market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Cardiac Glycosides is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cardiac Glycosides is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cardiac Glycosides is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cardiac Glycosides players cover Sanofi, Chengdu Beite Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd., Chengdu Haitong Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Cardiac Glycosides Industry Forecast” looks at past sales and reviews total world Cardiac Glycosides sales in 2025, providing a comprehensive analysis by region and market sector of projected Cardiac Glycosides sales for 2026 through 2032. With Cardiac Glycosides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiac Glycosides industry.
This Insight Report provides a comprehensive analysis of the global Cardiac Glycosides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiac Glycosides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiac Glycosides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiac Glycosides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiac Glycosides.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Glycosides market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Cardiac Glycosides market?
What factors are driving Cardiac Glycosides market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cardiac Glycosides market opportunities vary by end market size?
How does Cardiac Glycosides break out by Type, by Application?
United States market for Cardiac Glycosides is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cardiac Glycosides is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cardiac Glycosides is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cardiac Glycosides players cover Sanofi, Chengdu Beite Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd., Chengdu Haitong Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Cardiac Glycosides Industry Forecast” looks at past sales and reviews total world Cardiac Glycosides sales in 2025, providing a comprehensive analysis by region and market sector of projected Cardiac Glycosides sales for 2026 through 2032. With Cardiac Glycosides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiac Glycosides industry.
This Insight Report provides a comprehensive analysis of the global Cardiac Glycosides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiac Glycosides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiac Glycosides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiac Glycosides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiac Glycosides.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Glycosides market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Digoxin
- Scutellarin K
- Deacetylated Scutellarin
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Chengdu Beite Pharmaceutical Co., Ltd.
- Southwest Pharmaceutical Co., Ltd.
- Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd.
- Chengdu Haitong Pharmaceutical Co., Ltd.
- Harbin Pharmaceutical Group Pharmaceutical Factory No. 6
- China Resources Double Crane Pharmaceutical Co., Ltd.
- Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
- Shandong Weizhi Baike Pharmaceutical Co., Ltd.
- Shanghai Zhaohui Pharmaceutical Co., Ltd.
What is the 10-year outlook for the global Cardiac Glycosides market?
What factors are driving Cardiac Glycosides market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cardiac Glycosides market opportunities vary by end market size?
How does Cardiac Glycosides break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cardiac Glycosides Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Cardiac Glycosides by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Cardiac Glycosides by Country/Region, 2021, 2025 & 2032
2.2 Cardiac Glycosides Segment by Type
2.2.1 Digoxin
2.2.2 Scutellarin K
2.2.3 Deacetylated Scutellarin
2.2.4 Cardiac Glycosides Sales by Type
2.2.4.1 Global Cardiac Glycosides Sales Market Share by Type (2021-2026)
2.2.4.2 Global Cardiac Glycosides Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Cardiac Glycosides Sale Price by Type (2021-2026)
2.3 Cardiac Glycosides Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Cardiac Glycosides Sales by Application
2.3.4.1 Global Cardiac Glycosides Sale Market Share by Application (2021-2026)
2.3.4.2 Global Cardiac Glycosides Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Cardiac Glycosides Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Cardiac Glycosides Breakdown Data by Company
3.1.1 Global Cardiac Glycosides Annual Sales by Company (2021-2026)
3.1.2 Global Cardiac Glycosides Sales Market Share by Company (2021-2026)
3.2 Global Cardiac Glycosides Annual Revenue by Company (2021-2026)
3.2.1 Global Cardiac Glycosides Revenue by Company (2021-2026)
3.2.2 Global Cardiac Glycosides Revenue Market Share by Company (2021-2026)
3.3 Global Cardiac Glycosides Sale Price by Company
3.4 Key Manufacturers Cardiac Glycosides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cardiac Glycosides Product Location Distribution
3.4.2 Players Cardiac Glycosides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CARDIAC GLYCOSIDES BY GEOGRAPHIC REGION
4.1 World Historic Cardiac Glycosides Market Size by Geographic Region (2021-2026)
4.1.1 Global Cardiac Glycosides Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Cardiac Glycosides Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Cardiac Glycosides Market Size by Country/Region (2021-2026)
4.2.1 Global Cardiac Glycosides Annual Sales by Country/Region (2021-2026)
4.2.2 Global Cardiac Glycosides Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cardiac Glycosides Sales Growth
4.4 APAC Cardiac Glycosides Sales Growth
4.5 Europe Cardiac Glycosides Sales Growth
4.6 Middle East & Africa Cardiac Glycosides Sales Growth
5 AMERICAS
5.1 Americas Cardiac Glycosides Sales by Country
5.1.1 Americas Cardiac Glycosides Sales by Country (2021-2026)
5.1.2 Americas Cardiac Glycosides Revenue by Country (2021-2026)
5.2 Americas Cardiac Glycosides Sales by Type (2021-2026)
5.3 Americas Cardiac Glycosides Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cardiac Glycosides Sales by Region
6.1.1 APAC Cardiac Glycosides Sales by Region (2021-2026)
6.1.2 APAC Cardiac Glycosides Revenue by Region (2021-2026)
6.2 APAC Cardiac Glycosides Sales by Type (2021-2026)
6.3 APAC Cardiac Glycosides Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cardiac Glycosides by Country
7.1.1 Europe Cardiac Glycosides Sales by Country (2021-2026)
7.1.2 Europe Cardiac Glycosides Revenue by Country (2021-2026)
7.2 Europe Cardiac Glycosides Sales by Type (2021-2026)
7.3 Europe Cardiac Glycosides Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cardiac Glycosides by Country
8.1.1 Middle East & Africa Cardiac Glycosides Sales by Country (2021-2026)
8.1.2 Middle East & Africa Cardiac Glycosides Revenue by Country (2021-2026)
8.2 Middle East & Africa Cardiac Glycosides Sales by Type (2021-2026)
8.3 Middle East & Africa Cardiac Glycosides Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cardiac Glycosides
10.3 Manufacturing Process Analysis of Cardiac Glycosides
10.4 Industry Chain Structure of Cardiac Glycosides
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cardiac Glycosides Distributors
11.3 Cardiac Glycosides Customer
12 WORLD FORECAST REVIEW FOR CARDIAC GLYCOSIDES BY GEOGRAPHIC REGION
12.1 Global Cardiac Glycosides Market Size Forecast by Region
12.1.1 Global Cardiac Glycosides Forecast by Region (2027-2032)
12.1.2 Global Cardiac Glycosides Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Cardiac Glycosides Forecast by Type (2027-2032)
12.7 Global Cardiac Glycosides Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Cardiac Glycosides Product Portfolios and Specifications
13.1.3 Sanofi Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Chengdu Beite Pharmaceutical Co., Ltd.
13.2.1 Chengdu Beite Pharmaceutical Co., Ltd. Company Information
13.2.2 Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.2.3 Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Chengdu Beite Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Chengdu Beite Pharmaceutical Co., Ltd. Latest Developments
13.3 Southwest Pharmaceutical Co., Ltd.
13.3.1 Southwest Pharmaceutical Co., Ltd. Company Information
13.3.2 Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.3.3 Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Southwest Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Southwest Pharmaceutical Co., Ltd. Latest Developments
13.4 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd.
13.4.1 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Company Information
13.4.2 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.4.3 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Latest Developments
13.5 Chengdu Haitong Pharmaceutical Co., Ltd.
13.5.1 Chengdu Haitong Pharmaceutical Co., Ltd. Company Information
13.5.2 Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.5.3 Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Chengdu Haitong Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Chengdu Haitong Pharmaceutical Co., Ltd. Latest Developments
13.6 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6
13.6.1 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Company Information
13.6.2 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Product Portfolios and Specifications
13.6.3 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Main Business Overview
13.6.5 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Latest Developments
13.7 China Resources Double Crane Pharmaceutical Co., Ltd.
13.7.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
13.7.2 China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.7.3 China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 China Resources Double Crane Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 China Resources Double Crane Pharmaceutical Co., Ltd. Latest Developments
13.8 Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
13.8.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Company Information
13.8.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.8.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Latest Developments
13.9 Shandong Weizhi Baike Pharmaceutical Co., Ltd.
13.9.1 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Company Information
13.9.2 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.9.3 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Latest Developments
13.10 Shanghai Zhaohui Pharmaceutical Co., Ltd.
13.10.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
13.10.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.10.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cardiac Glycosides Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Cardiac Glycosides by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Cardiac Glycosides by Country/Region, 2021, 2025 & 2032
2.2 Cardiac Glycosides Segment by Type
2.2.1 Digoxin
2.2.2 Scutellarin K
2.2.3 Deacetylated Scutellarin
2.2.4 Cardiac Glycosides Sales by Type
2.2.4.1 Global Cardiac Glycosides Sales Market Share by Type (2021-2026)
2.2.4.2 Global Cardiac Glycosides Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Cardiac Glycosides Sale Price by Type (2021-2026)
2.3 Cardiac Glycosides Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Cardiac Glycosides Sales by Application
2.3.4.1 Global Cardiac Glycosides Sale Market Share by Application (2021-2026)
2.3.4.2 Global Cardiac Glycosides Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Cardiac Glycosides Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Cardiac Glycosides Breakdown Data by Company
3.1.1 Global Cardiac Glycosides Annual Sales by Company (2021-2026)
3.1.2 Global Cardiac Glycosides Sales Market Share by Company (2021-2026)
3.2 Global Cardiac Glycosides Annual Revenue by Company (2021-2026)
3.2.1 Global Cardiac Glycosides Revenue by Company (2021-2026)
3.2.2 Global Cardiac Glycosides Revenue Market Share by Company (2021-2026)
3.3 Global Cardiac Glycosides Sale Price by Company
3.4 Key Manufacturers Cardiac Glycosides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cardiac Glycosides Product Location Distribution
3.4.2 Players Cardiac Glycosides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CARDIAC GLYCOSIDES BY GEOGRAPHIC REGION
4.1 World Historic Cardiac Glycosides Market Size by Geographic Region (2021-2026)
4.1.1 Global Cardiac Glycosides Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Cardiac Glycosides Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Cardiac Glycosides Market Size by Country/Region (2021-2026)
4.2.1 Global Cardiac Glycosides Annual Sales by Country/Region (2021-2026)
4.2.2 Global Cardiac Glycosides Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cardiac Glycosides Sales Growth
4.4 APAC Cardiac Glycosides Sales Growth
4.5 Europe Cardiac Glycosides Sales Growth
4.6 Middle East & Africa Cardiac Glycosides Sales Growth
5 AMERICAS
5.1 Americas Cardiac Glycosides Sales by Country
5.1.1 Americas Cardiac Glycosides Sales by Country (2021-2026)
5.1.2 Americas Cardiac Glycosides Revenue by Country (2021-2026)
5.2 Americas Cardiac Glycosides Sales by Type (2021-2026)
5.3 Americas Cardiac Glycosides Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cardiac Glycosides Sales by Region
6.1.1 APAC Cardiac Glycosides Sales by Region (2021-2026)
6.1.2 APAC Cardiac Glycosides Revenue by Region (2021-2026)
6.2 APAC Cardiac Glycosides Sales by Type (2021-2026)
6.3 APAC Cardiac Glycosides Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cardiac Glycosides by Country
7.1.1 Europe Cardiac Glycosides Sales by Country (2021-2026)
7.1.2 Europe Cardiac Glycosides Revenue by Country (2021-2026)
7.2 Europe Cardiac Glycosides Sales by Type (2021-2026)
7.3 Europe Cardiac Glycosides Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cardiac Glycosides by Country
8.1.1 Middle East & Africa Cardiac Glycosides Sales by Country (2021-2026)
8.1.2 Middle East & Africa Cardiac Glycosides Revenue by Country (2021-2026)
8.2 Middle East & Africa Cardiac Glycosides Sales by Type (2021-2026)
8.3 Middle East & Africa Cardiac Glycosides Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cardiac Glycosides
10.3 Manufacturing Process Analysis of Cardiac Glycosides
10.4 Industry Chain Structure of Cardiac Glycosides
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cardiac Glycosides Distributors
11.3 Cardiac Glycosides Customer
12 WORLD FORECAST REVIEW FOR CARDIAC GLYCOSIDES BY GEOGRAPHIC REGION
12.1 Global Cardiac Glycosides Market Size Forecast by Region
12.1.1 Global Cardiac Glycosides Forecast by Region (2027-2032)
12.1.2 Global Cardiac Glycosides Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Cardiac Glycosides Forecast by Type (2027-2032)
12.7 Global Cardiac Glycosides Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Cardiac Glycosides Product Portfolios and Specifications
13.1.3 Sanofi Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Chengdu Beite Pharmaceutical Co., Ltd.
13.2.1 Chengdu Beite Pharmaceutical Co., Ltd. Company Information
13.2.2 Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.2.3 Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Chengdu Beite Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Chengdu Beite Pharmaceutical Co., Ltd. Latest Developments
13.3 Southwest Pharmaceutical Co., Ltd.
13.3.1 Southwest Pharmaceutical Co., Ltd. Company Information
13.3.2 Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.3.3 Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Southwest Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Southwest Pharmaceutical Co., Ltd. Latest Developments
13.4 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd.
13.4.1 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Company Information
13.4.2 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.4.3 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Latest Developments
13.5 Chengdu Haitong Pharmaceutical Co., Ltd.
13.5.1 Chengdu Haitong Pharmaceutical Co., Ltd. Company Information
13.5.2 Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.5.3 Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Chengdu Haitong Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Chengdu Haitong Pharmaceutical Co., Ltd. Latest Developments
13.6 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6
13.6.1 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Company Information
13.6.2 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Product Portfolios and Specifications
13.6.3 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Main Business Overview
13.6.5 Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Latest Developments
13.7 China Resources Double Crane Pharmaceutical Co., Ltd.
13.7.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
13.7.2 China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.7.3 China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 China Resources Double Crane Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 China Resources Double Crane Pharmaceutical Co., Ltd. Latest Developments
13.8 Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
13.8.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Company Information
13.8.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.8.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Latest Developments
13.9 Shandong Weizhi Baike Pharmaceutical Co., Ltd.
13.9.1 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Company Information
13.9.2 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.9.3 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Shandong Weizhi Baike Pharmaceutical Co., Ltd. Latest Developments
13.10 Shanghai Zhaohui Pharmaceutical Co., Ltd.
13.10.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
13.10.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
13.10.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cardiac Glycosides Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Cardiac Glycosides Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Digoxin
Table 4. Major Players of Scutellarin K
Table 5. Major Players of Deacetylated Scutellarin
Table 6. Global Cardiac Glycosides Sales by Type (2021-2026) & (K Units)
Table 7. Global Cardiac Glycosides Sales Market Share by Type (2021-2026)
Table 8. Global Cardiac Glycosides Revenue by Type (2021-2026) & ($ million)
Table 9. Global Cardiac Glycosides Revenue Market Share by Type (2021-2026)
Table 10. Global Cardiac Glycosides Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Cardiac Glycosides Sale by Application (2021-2026) & (K Units)
Table 12. Global Cardiac Glycosides Sale Market Share by Application (2021-2026)
Table 13. Global Cardiac Glycosides Revenue by Application (2021-2026) & ($ million)
Table 14. Global Cardiac Glycosides Revenue Market Share by Application (2021-2026)
Table 15. Global Cardiac Glycosides Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Cardiac Glycosides Sales by Company (2021-2026) & (K Units)
Table 17. Global Cardiac Glycosides Sales Market Share by Company (2021-2026)
Table 18. Global Cardiac Glycosides Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Cardiac Glycosides Revenue Market Share by Company (2021-2026)
Table 20. Global Cardiac Glycosides Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Cardiac Glycosides Producing Area Distribution and Sales Area
Table 22. Players Cardiac Glycosides Products Offered
Table 23. Cardiac Glycosides Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Cardiac Glycosides Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Cardiac Glycosides Sales Market Share Geographic Region (2021-2026)
Table 28. Global Cardiac Glycosides Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Cardiac Glycosides Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Cardiac Glycosides Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Cardiac Glycosides Sales Market Share by Country/Region (2021-2026)
Table 32. Global Cardiac Glycosides Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Cardiac Glycosides Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Cardiac Glycosides Sales by Country (2021-2026) & (K Units)
Table 35. Americas Cardiac Glycosides Sales Market Share by Country (2021-2026)
Table 36. Americas Cardiac Glycosides Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Cardiac Glycosides Sales by Type (2021-2026) & (K Units)
Table 38. Americas Cardiac Glycosides Sales by Application (2021-2026) & (K Units)
Table 39. APAC Cardiac Glycosides Sales by Region (2021-2026) & (K Units)
Table 40. APAC Cardiac Glycosides Sales Market Share by Region (2021-2026)
Table 41. APAC Cardiac Glycosides Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Cardiac Glycosides Sales by Type (2021-2026) & (K Units)
Table 43. APAC Cardiac Glycosides Sales by Application (2021-2026) & (K Units)
Table 44. Europe Cardiac Glycosides Sales by Country (2021-2026) & (K Units)
Table 45. Europe Cardiac Glycosides Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Cardiac Glycosides Sales by Type (2021-2026) & (K Units)
Table 47. Europe Cardiac Glycosides Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Cardiac Glycosides Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Cardiac Glycosides Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Cardiac Glycosides Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Cardiac Glycosides Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Cardiac Glycosides
Table 53. Key Market Challenges & Risks of Cardiac Glycosides
Table 54. Key Industry Trends of Cardiac Glycosides
Table 55. Cardiac Glycosides Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Cardiac Glycosides Distributors List
Table 58. Cardiac Glycosides Customer List
Table 59. Global Cardiac Glycosides Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Cardiac Glycosides Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Cardiac Glycosides Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Cardiac Glycosides Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Cardiac Glycosides Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Cardiac Glycosides Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Cardiac Glycosides Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Cardiac Glycosides Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Cardiac Glycosides Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Cardiac Glycosides Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Cardiac Glycosides Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Cardiac Glycosides Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Cardiac Glycosides Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Cardiac Glycosides Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Sanofi Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 74. Sanofi Cardiac Glycosides Product Portfolios and Specifications
Table 75. Sanofi Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Sanofi Main Business
Table 77. Sanofi Latest Developments
Table 78. Chengdu Beite Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 79. Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 80. Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Chengdu Beite Pharmaceutical Co., Ltd. Main Business
Table 82. Chengdu Beite Pharmaceutical Co., Ltd. Latest Developments
Table 83. Southwest Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 84. Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 85. Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Southwest Pharmaceutical Co., Ltd. Main Business
Table 87. Southwest Pharmaceutical Co., Ltd. Latest Developments
Table 88. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 89. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 90. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Main Business
Table 92. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Latest Developments
Table 93. Chengdu Haitong Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 94. Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 95. Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Chengdu Haitong Pharmaceutical Co., Ltd. Main Business
Table 97. Chengdu Haitong Pharmaceutical Co., Ltd. Latest Developments
Table 98. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 99. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Product Portfolios and Specifications
Table 100. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Main Business
Table 102. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Latest Developments
Table 103. China Resources Double Crane Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 104. China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 105. China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. China Resources Double Crane Pharmaceutical Co., Ltd. Main Business
Table 107. China Resources Double Crane Pharmaceutical Co., Ltd. Latest Developments
Table 108. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 109. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 110. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Main Business
Table 112. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Latest Developments
Table 113. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 114. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 115. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Main Business
Table 117. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Latest Developments
Table 118. Shanghai Zhaohui Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 120. Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Shanghai Zhaohui Pharmaceutical Co., Ltd. Main Business
Table 122. Shanghai Zhaohui Pharmaceutical Co., Ltd. Latest Developments
Table 1. Cardiac Glycosides Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Cardiac Glycosides Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Digoxin
Table 4. Major Players of Scutellarin K
Table 5. Major Players of Deacetylated Scutellarin
Table 6. Global Cardiac Glycosides Sales by Type (2021-2026) & (K Units)
Table 7. Global Cardiac Glycosides Sales Market Share by Type (2021-2026)
Table 8. Global Cardiac Glycosides Revenue by Type (2021-2026) & ($ million)
Table 9. Global Cardiac Glycosides Revenue Market Share by Type (2021-2026)
Table 10. Global Cardiac Glycosides Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Cardiac Glycosides Sale by Application (2021-2026) & (K Units)
Table 12. Global Cardiac Glycosides Sale Market Share by Application (2021-2026)
Table 13. Global Cardiac Glycosides Revenue by Application (2021-2026) & ($ million)
Table 14. Global Cardiac Glycosides Revenue Market Share by Application (2021-2026)
Table 15. Global Cardiac Glycosides Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Cardiac Glycosides Sales by Company (2021-2026) & (K Units)
Table 17. Global Cardiac Glycosides Sales Market Share by Company (2021-2026)
Table 18. Global Cardiac Glycosides Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Cardiac Glycosides Revenue Market Share by Company (2021-2026)
Table 20. Global Cardiac Glycosides Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Cardiac Glycosides Producing Area Distribution and Sales Area
Table 22. Players Cardiac Glycosides Products Offered
Table 23. Cardiac Glycosides Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Cardiac Glycosides Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Cardiac Glycosides Sales Market Share Geographic Region (2021-2026)
Table 28. Global Cardiac Glycosides Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Cardiac Glycosides Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Cardiac Glycosides Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Cardiac Glycosides Sales Market Share by Country/Region (2021-2026)
Table 32. Global Cardiac Glycosides Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Cardiac Glycosides Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Cardiac Glycosides Sales by Country (2021-2026) & (K Units)
Table 35. Americas Cardiac Glycosides Sales Market Share by Country (2021-2026)
Table 36. Americas Cardiac Glycosides Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Cardiac Glycosides Sales by Type (2021-2026) & (K Units)
Table 38. Americas Cardiac Glycosides Sales by Application (2021-2026) & (K Units)
Table 39. APAC Cardiac Glycosides Sales by Region (2021-2026) & (K Units)
Table 40. APAC Cardiac Glycosides Sales Market Share by Region (2021-2026)
Table 41. APAC Cardiac Glycosides Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Cardiac Glycosides Sales by Type (2021-2026) & (K Units)
Table 43. APAC Cardiac Glycosides Sales by Application (2021-2026) & (K Units)
Table 44. Europe Cardiac Glycosides Sales by Country (2021-2026) & (K Units)
Table 45. Europe Cardiac Glycosides Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Cardiac Glycosides Sales by Type (2021-2026) & (K Units)
Table 47. Europe Cardiac Glycosides Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Cardiac Glycosides Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Cardiac Glycosides Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Cardiac Glycosides Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Cardiac Glycosides Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Cardiac Glycosides
Table 53. Key Market Challenges & Risks of Cardiac Glycosides
Table 54. Key Industry Trends of Cardiac Glycosides
Table 55. Cardiac Glycosides Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Cardiac Glycosides Distributors List
Table 58. Cardiac Glycosides Customer List
Table 59. Global Cardiac Glycosides Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Cardiac Glycosides Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Cardiac Glycosides Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Cardiac Glycosides Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Cardiac Glycosides Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Cardiac Glycosides Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Cardiac Glycosides Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Cardiac Glycosides Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Cardiac Glycosides Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Cardiac Glycosides Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Cardiac Glycosides Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Cardiac Glycosides Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Cardiac Glycosides Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Cardiac Glycosides Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Sanofi Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 74. Sanofi Cardiac Glycosides Product Portfolios and Specifications
Table 75. Sanofi Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Sanofi Main Business
Table 77. Sanofi Latest Developments
Table 78. Chengdu Beite Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 79. Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 80. Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Chengdu Beite Pharmaceutical Co., Ltd. Main Business
Table 82. Chengdu Beite Pharmaceutical Co., Ltd. Latest Developments
Table 83. Southwest Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 84. Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 85. Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Southwest Pharmaceutical Co., Ltd. Main Business
Table 87. Southwest Pharmaceutical Co., Ltd. Latest Developments
Table 88. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 89. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 90. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Main Business
Table 92. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Latest Developments
Table 93. Chengdu Haitong Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 94. Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 95. Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Chengdu Haitong Pharmaceutical Co., Ltd. Main Business
Table 97. Chengdu Haitong Pharmaceutical Co., Ltd. Latest Developments
Table 98. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 99. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Product Portfolios and Specifications
Table 100. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Main Business
Table 102. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Latest Developments
Table 103. China Resources Double Crane Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 104. China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 105. China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. China Resources Double Crane Pharmaceutical Co., Ltd. Main Business
Table 107. China Resources Double Crane Pharmaceutical Co., Ltd. Latest Developments
Table 108. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 109. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 110. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Main Business
Table 112. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Latest Developments
Table 113. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 114. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 115. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Main Business
Table 117. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Latest Developments
Table 118. Shanghai Zhaohui Pharmaceutical Co., Ltd. Basic Information, Cardiac Glycosides Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Product Portfolios and Specifications
Table 120. Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Shanghai Zhaohui Pharmaceutical Co., Ltd. Main Business
Table 122. Shanghai Zhaohui Pharmaceutical Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Cardiac Glycosides
Figure 2. Cardiac Glycosides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cardiac Glycosides Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Cardiac Glycosides Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Cardiac Glycosides Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Cardiac Glycosides Sales Market Share by Country/Region (2025)
Figure 10. Cardiac Glycosides Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Digoxin
Figure 12. Product Picture of Scutellarin K
Figure 13. Product Picture of Deacetylated Scutellarin
Figure 14. Global Cardiac Glycosides Sales Market Share by Type in 2026
Figure 15. Global Cardiac Glycosides Revenue Market Share by Type (2021-2026)
Figure 16. Cardiac Glycosides Consumed in Hospital
Figure 17. Global Cardiac Glycosides Market: Hospital (2021-2026) & (K Units)
Figure 18. Cardiac Glycosides Consumed in Clinic
Figure 19. Global Cardiac Glycosides Market: Clinic (2021-2026) & (K Units)
Figure 20. Cardiac Glycosides Consumed in Other
Figure 21. Global Cardiac Glycosides Market: Other (2021-2026) & (K Units)
Figure 22. Global Cardiac Glycosides Sale Market Share by Application (2025)
Figure 23. Global Cardiac Glycosides Revenue Market Share by Application in 2026
Figure 24. Cardiac Glycosides Sales by Company in 2026 (K Units)
Figure 25. Global Cardiac Glycosides Sales Market Share by Company in 2026
Figure 26. Cardiac Glycosides Revenue by Company in 2026 ($ millions)
Figure 27. Global Cardiac Glycosides Revenue Market Share by Company in 2026
Figure 28. Global Cardiac Glycosides Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Cardiac Glycosides Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Cardiac Glycosides Sales 2021-2026 (K Units)
Figure 31. Americas Cardiac Glycosides Revenue 2021-2026 ($ millions)
Figure 32. APAC Cardiac Glycosides Sales 2021-2026 (K Units)
Figure 33. APAC Cardiac Glycosides Revenue 2021-2026 ($ millions)
Figure 34. Europe Cardiac Glycosides Sales 2021-2026 (K Units)
Figure 35. Europe Cardiac Glycosides Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Cardiac Glycosides Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Cardiac Glycosides Revenue 2021-2026 ($ millions)
Figure 38. Americas Cardiac Glycosides Sales Market Share by Country in 2026
Figure 39. Americas Cardiac Glycosides Revenue Market Share by Country (2021-2026)
Figure 40. Americas Cardiac Glycosides Sales Market Share by Type (2021-2026)
Figure 41. Americas Cardiac Glycosides Sales Market Share by Application (2021-2026)
Figure 42. United States Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Cardiac Glycosides Sales Market Share by Region in 2026
Figure 47. APAC Cardiac Glycosides Revenue Market Share by Region (2021-2026)
Figure 48. APAC Cardiac Glycosides Sales Market Share by Type (2021-2026)
Figure 49. APAC Cardiac Glycosides Sales Market Share by Application (2021-2026)
Figure 50. China Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 54. India Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Cardiac Glycosides Sales Market Share by Country in 2026
Figure 58. Europe Cardiac Glycosides Revenue Market Share by Country (2021-2026)
Figure 59. Europe Cardiac Glycosides Sales Market Share by Type (2021-2026)
Figure 60. Europe Cardiac Glycosides Sales Market Share by Application (2021-2026)
Figure 61. Germany Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 62. France Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Cardiac Glycosides Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Cardiac Glycosides Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Cardiac Glycosides Sales Market Share by Application (2021-2026)
Figure 69. Egypt Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Cardiac Glycosides in 2026
Figure 75. Manufacturing Process Analysis of Cardiac Glycosides
Figure 76. Industry Chain Structure of Cardiac Glycosides
Figure 77. Channels of Distribution
Figure 78. Global Cardiac Glycosides Sales Market Forecast by Region (2027-2032)
Figure 79. Global Cardiac Glycosides Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Cardiac Glycosides Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Cardiac Glycosides Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Cardiac Glycosides Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Cardiac Glycosides Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Cardiac Glycosides
Figure 2. Cardiac Glycosides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cardiac Glycosides Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Cardiac Glycosides Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Cardiac Glycosides Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Cardiac Glycosides Sales Market Share by Country/Region (2025)
Figure 10. Cardiac Glycosides Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Digoxin
Figure 12. Product Picture of Scutellarin K
Figure 13. Product Picture of Deacetylated Scutellarin
Figure 14. Global Cardiac Glycosides Sales Market Share by Type in 2026
Figure 15. Global Cardiac Glycosides Revenue Market Share by Type (2021-2026)
Figure 16. Cardiac Glycosides Consumed in Hospital
Figure 17. Global Cardiac Glycosides Market: Hospital (2021-2026) & (K Units)
Figure 18. Cardiac Glycosides Consumed in Clinic
Figure 19. Global Cardiac Glycosides Market: Clinic (2021-2026) & (K Units)
Figure 20. Cardiac Glycosides Consumed in Other
Figure 21. Global Cardiac Glycosides Market: Other (2021-2026) & (K Units)
Figure 22. Global Cardiac Glycosides Sale Market Share by Application (2025)
Figure 23. Global Cardiac Glycosides Revenue Market Share by Application in 2026
Figure 24. Cardiac Glycosides Sales by Company in 2026 (K Units)
Figure 25. Global Cardiac Glycosides Sales Market Share by Company in 2026
Figure 26. Cardiac Glycosides Revenue by Company in 2026 ($ millions)
Figure 27. Global Cardiac Glycosides Revenue Market Share by Company in 2026
Figure 28. Global Cardiac Glycosides Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Cardiac Glycosides Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Cardiac Glycosides Sales 2021-2026 (K Units)
Figure 31. Americas Cardiac Glycosides Revenue 2021-2026 ($ millions)
Figure 32. APAC Cardiac Glycosides Sales 2021-2026 (K Units)
Figure 33. APAC Cardiac Glycosides Revenue 2021-2026 ($ millions)
Figure 34. Europe Cardiac Glycosides Sales 2021-2026 (K Units)
Figure 35. Europe Cardiac Glycosides Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Cardiac Glycosides Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Cardiac Glycosides Revenue 2021-2026 ($ millions)
Figure 38. Americas Cardiac Glycosides Sales Market Share by Country in 2026
Figure 39. Americas Cardiac Glycosides Revenue Market Share by Country (2021-2026)
Figure 40. Americas Cardiac Glycosides Sales Market Share by Type (2021-2026)
Figure 41. Americas Cardiac Glycosides Sales Market Share by Application (2021-2026)
Figure 42. United States Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Cardiac Glycosides Sales Market Share by Region in 2026
Figure 47. APAC Cardiac Glycosides Revenue Market Share by Region (2021-2026)
Figure 48. APAC Cardiac Glycosides Sales Market Share by Type (2021-2026)
Figure 49. APAC Cardiac Glycosides Sales Market Share by Application (2021-2026)
Figure 50. China Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 54. India Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Cardiac Glycosides Sales Market Share by Country in 2026
Figure 58. Europe Cardiac Glycosides Revenue Market Share by Country (2021-2026)
Figure 59. Europe Cardiac Glycosides Sales Market Share by Type (2021-2026)
Figure 60. Europe Cardiac Glycosides Sales Market Share by Application (2021-2026)
Figure 61. Germany Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 62. France Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Cardiac Glycosides Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Cardiac Glycosides Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Cardiac Glycosides Sales Market Share by Application (2021-2026)
Figure 69. Egypt Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Cardiac Glycosides Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Cardiac Glycosides in 2026
Figure 75. Manufacturing Process Analysis of Cardiac Glycosides
Figure 76. Industry Chain Structure of Cardiac Glycosides
Figure 77. Channels of Distribution
Figure 78. Global Cardiac Glycosides Sales Market Forecast by Region (2027-2032)
Figure 79. Global Cardiac Glycosides Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Cardiac Glycosides Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Cardiac Glycosides Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Cardiac Glycosides Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Cardiac Glycosides Revenue Market Share Forecast by Application (2027-2032)
